Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Rx Technologies Corp.Financial_Report.xls

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q /A

Amendment No. 1


þ

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended September 30, 2012


OR


o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from ___________ to ___________

 

Commission file number 333-156942

 

Rx Technologies Corp.

(Exact name of registrant as specified in its charter)


Florida

 

26-3891952

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification Number)


7076 Spyglass Avenue, Parkland, Florida

 

33076

(Address of principal executive offices)

 

(Zip Code)


(954) 599-3672

(Issuer’s telephone number, including area code)


Not Applicable

(Former name, former address and former fiscal year, if changed since last report)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ     No o


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes þ     No o


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):


 

Large accelerated filer

o

Accelerated filer

o

 

Non-accelerated filer

o

Smaller reporting company

þ

(Do not check if a smaller reporting company)


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o     No þ


Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.


Class

 

Outstanding at October 15, 2012

Common Stock, $0.001

 

94,441,850 shares




EXPLANATORY NOTE


The purpose of this Amendment No. 1 to the Quarterly Report on Form 10-Q for the period ended September 30, 2012 (“Form 10-Q”) is to submit Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T.  Exhibit 101 consists of the Interactive Data Files relating to the Form 10-Q for the period ended September 30, 2012, filed with the Securities and Exchange Commission on December 11, 2012.



PART II OTHER INFORMATION


Item 6.  Exhibits


(a)          Exhibits


Exhibit No.

Description

 

 

31.1 *

Rule 13a-14(a)/15d-14(a) Certification of President and Principal Executive Officer

31.2 *

Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer and Principal Accounting Officer

32.1 *

Section 1350 Certification of President and Principal Executive Officer

32.2 *

Section 1350 Certification of Chief Financial Officer and Principal Accounting Officer

101 **

XBRL data files of Financial Statements and Notes contained in this Quarterly Report on Form 10-Q


* Previously submitted.


* In accordance with Regulation S-T, the Interactive Data Files in Exhibit 101 to the Quarterly Report on Form 10-Q shall be deemed “furnished” and not “filed”.



SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 

 

RX TECHNOLOGIES CORP.

 

 

 

DATE:   April 9, 2013

By:

/s/ Michael McManus

 

 

Michael McManus

 

 

President and Principal Executive Officer


- 2 -